Aligos Therapeutics (ALGS) Current Leases (2019 - 2026)
Aligos Therapeutics (ALGS) reported Current Leases of $3.6 million for Q1 2026, up 9662.16% on a YoY basis from $37000.0 in Q1 2025, and up 2391.03% quarter-over-quarter from $145000.0 in Q4 2025.
Aligos Therapeutics (ALGS) Current Leases (2019 - 2026) Analysis & Trends
Aligos Therapeutics has reported Current Leases for 8 years, with the latest figure at $3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 9662.16% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (up 9662.16% YoY), and the FY2025 full-year result was $145000.0, up 302.78% from the prior year.
- Current Leases for Q1 2026 stood at $3.6 million, up from $145000.0 in the prior quarter.
- The five-year high for Current Leases was $3.6 million in Q1 2026, with the low at $13000.0 in Q3 2024.
- Historically, Current Leases has averaged $1.4 million across 5 years, with a median of $138000.0 in 2022.
- Annual changes were most pronounced in 2024 — Current Leases sank 99.59% — and 2026, when it surged 9662.16%.
- Aligos Therapeutics' Current Leases stood at $108000.0 in 2022, then soared by 2889.81% to $3.2 million in 2023, then slumped by 98.89% to $36000.0 in 2024, then soared by 302.78% to $145000.0 in 2025, then surged by 2391.03% to $3.6 million in 2026.
- The last three Current Leases figures came in at $3.6 million (Q1 2026), $145000.0 (Q4 2025), and $21000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 42,980.09 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Aligos Therapeutics | 54.72 Mn | -25.11 Mn | - | 3.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.61 Mn |
| Dec 31, 2025 | 145,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 3.35 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | 3.23 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 3.17 Mn |
| Mar 31, 2023 | 3.04 Mn |
| Dec 31, 2022 | 108,000.00 |
| Sep 30, 2022 | 138,000.00 |
| Jun 30, 2022 | 138,000.00 |
| Mar 31, 2022 | 138,000.00 |
| Dec 31, 2021 | 138,000.00 |
| Sep 30, 2021 | 2.70 Mn |
| Jun 30, 2021 | 26,000.00 |